Global medicines company for developing and producing drugs.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.
Visit website: https://www.novartis.com/
Prescription gene therapy product for treatment of inherited retinal disease
People at Novartis
Chief Executive Officer of Novartis.
Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.
$95M raised by Taysha for clinical trials of four new gene therapies
FierceBiotech - 05-Aug-2020
Company has gathered support from investors to quickly lead therapies to clinic then marketRead more...
Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next yearRead more...
First gene therapy for a rare eye disease, now NHS-approved
BBC - 17-Feb-2020
This life-changing new gene therapy will halt sight loss and improve visionRead more...
Competitors in big pharma accused of conspiring to inflate generic drug prices
Independent - 12-May-2019
Inflated prices of more than 100 generic drugs by as much as 1000 per centRead more...